Skip to main content
Hae Seung Lee, MD, Endocrinology, Torrance, CA

Hae SeungLeeMDPhD(She/Her)

Endocrinology Torrance, CA

Diabetes, Obesity, Thyroid

Director

Dr. Lee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Lee's full profile

Already have an account?

  • Office

    4201 Torrance Blvd
    Ste 750
    Torrance, CA 90503
    Phone+1 424-210-5484

Education & Training

  • Los Angeles County-Harbor-UCLA Medical Center
    Los Angeles County-Harbor-UCLA Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2021 - 2023
  • New York Medical College (Metropolitan)
    New York Medical College (Metropolitan)Residency, Internal Medicine, 2013 - 2016
  • Soonchunhyang University Hospital Center
    Soonchunhyang University Hospital CenterInternal Medicine, 2006 - 2010
  • Soonchunhyang University Cheonan Hospital
    Soonchunhyang University Cheonan HospitalDiagnostic Radiology, 2004 - 2005
  • Soonchunhyang University Cheonan Hospital
    Soonchunhyang University Cheonan HospitalTransitional year, 2003 - 2004
  • Soonchunhyang University School of Medicine
    Soonchunhyang University School of Medicine Medical Doctor, 1997 - 2003

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2021 - 2027
  • NY State Medical License
    NY State Medical License 2016 - 2022
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
  • American Board of Obesity Medicine Obesity Medicine

Awards, Honors, & Recognition

  • Outstanding Oral Abstract ENDO 2023, Endocrine Society, 2023
  • Assistant Chief Resident Metropolitan Hospital Center, 2016
  • Best resident award Metropolitan hospital, 2014

Publications & Presentations

PubMed

Journal Articles

  • The Effect of Testosterone Replacement Therapy on NAFLD in Elderly Hypogonadal Men  
    HS Lee, SH Han, R Swerdloff, C Wang, Y Pak, P Snyder, M Budoff, JECM
  • The Area of Ground Glass Opacities of the Lungs as a Predictive Factor in Acute Paraquat Intoxication  
    YT Kim, SH Jou, HS Lee, HW Gil, JO Yang, EY Lee, SY Hong, J Korean Med Sci. 2009 Aug;24(4):636-640, 8/2009
  • The Use of Complementary and Alternative Medicine(CAM) for Prevention and Treatment of Osteoporosis in Postmenopausal Women  
    HS Lee, JY Kim, MO Roh, DW Byun, KI Seo, MH Yoo, HH Lee, JM Koh, DY Kim, YK Min, BS Lee, BI Lee, HM Park., Korean Journal of Bone Metabolism, 5/2009
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • The Effect of Testosterone Replacement Therapy on NAFLD in Elderly Hypogonadal Men
    HS Lee, SH Han, R Swerdloff, C Wang, Y Pak, P Snyder, M Budoff, ENDO 2023, Chicago, IL, 6/17/2023
  • Case report: hypocalcemia- A novel mutation of GATA3 gene causing hypoparathyroidism and unilateral agenesis of the kidney
    HS Lee, A Vera, R Swerdloff, H Lin, Oral presentation at Santa Fe Fellows Workshop on Osteoporosis and Metabolic Bone Diseases, Santa Fe, New Mexico, 8/2022
  • The Use of Complementary and Alternative Medicine (CAM) for Prevention and Treatment of Osteoporosis in Postmenopausal Women. Oral Presentation
    HS Lee, JY Kim, MO Roh, DW Byun, YI Seo, MH Yoo, HH Lee, JM Koh, DY Kim, YK Min, BS Lee, BY Lee, HM Park, 009 Spring Conference of Korean Society of Bone Metabolism, Seoul, South Korea, 5/2009
  • Join now to see all

Research History

  • Volunteer research facultyParticipating in clinical trials at Lundquist research institute, Harbor-UCLA2023 - Present
  • Sub-investigatorSafety and efficacy of Paltusotine for treatment of Acromegaly at Lundquist institute, Harbor-UCLA2021 - 2023
  • Sub-investigatorOpen-Label extension study of the Safety of Relacorilant in Cushing Syndrome at Lundquist institute, Harbor-UCLA2021 - 2023
  • Sub-investigatorphase 2 clinical trial of male contraception with combination of Testosterone and Nestorone transdermal gel. Lundquist Institute at Harbor-UCLA2021 - 2023

Professional Memberships

Other Languages

  • Korean